“This award recognizes researchers who, through their clinical cases, open new doors in the treatment and understanding of complex diseases in oncology and virology, with special attention to the patient.”

Dr. Louis Gros is a Swiss medical oncologist who has developed his career in prestigious institutions in Paris and New York. Trained under the tutelage of Professor Solange Peters in Lausanne and subsequently at Mount Sinai Hospital with Professor Claudia Henschke, his focus has been centered on oncology, especially lung cancer.

The PharmaMar Foundation has awarded Dr. Gros for his innovative work in the treatment of advanced and refractory peritoneal mesothelioma, conducted in collaboration with Dr. Antonia Digklia and titled “Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases”. Using lurbinectedin, this clinical case has marked an advance in the field of oncology, improving treatment options for patients with complex conditions.